Literature DB >> 18000202

Congress responds to the IOM drug safety report--in full.

Bruce M Psaty1, David Korn.   

Abstract

Mesh:

Year:  2007        PMID: 18000202     DOI: 10.1001/jama.298.18.2185

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  International society for disease surveillance conference 2011: building the future of public health surveillance.

Authors:  Daniel B Neill; Karl A Soetebier
Journal:  Emerg Health Threats J       Date:  2011-12-06

Review 2.  Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

Authors:  Jie Zhang; Huifeng Yun; Nicole C Wright; Meredith Kilgore; Kenneth G Saag; Elizabeth Delzell
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

Review 3.  Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Bethea A Kleykamp; Robert H Dworkin; Dennis C Turk; Zubin Bhagwagar; Penney Cowan; Christopher Eccleston; Susan S Ellenberg; Scott R Evans; John T Farrar; Roy L Freeman; Louis P Garrison; Jennifer S Gewandter; Veeraindar Goli; Smriti Iyengar; Alejandro R Jadad; Mark P Jensen; Roderick Junor; Nathaniel P Katz; J Patrick Kesslak; Ernest A Kopecky; Dmitri Lissin; John D Markman; Michael P McDermott; Philip J Mease; Alec B O'Connor; Kushang V Patel; Srinivasa N Raja; Michael C Rowbotham; Cristina Sampaio; Jasvinder A Singh; Ilona Steigerwald; Vibeke Strand; Leslie A Tive; Jeffrey Tobias; Ajay D Wasan; Hilary D Wilson
Journal:  Pain       Date:  2021-09-09       Impact factor: 7.926

4.  National trends in treatment of type 2 diabetes mellitus, 1994-2007.

Authors:  G Caleb Alexander; Niraj L Sehgal; Rachael M Moloney; Randall S Stafford
Journal:  Arch Intern Med       Date:  2008-10-27

Review 5.  Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumonia.

Authors:  Bruce M Psaty
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.